Camtek (NASDAQ:CAMT) CFO Sells $601,665.54 in Stock

Key Points

• Camtek CFO Moshe Eisenberg sold 3,759 shares for approximately $601,666, reducing his direct ownership by 18.21% to 16,884 shares. He also sold an additional 645 shares the following day for about $111,372.
• Camtek shares rose 0.5% to $175.01, while the company reported quarterly EPS of $0.78 and revenue of $133.24 million, exceeding analyst expectations; revenue increased 8% year over year.
• Analyst sentiment remains moderately positive, with a consensus rating of “Moderate Buy” and an average price target of $173.25, while institutional investors own 41.93% of the stock.

Camtek Ltd. (NASDAQ:CAMT - Get Free Report) CFO Moshe Eisenberg sold 3,759 shares of the business's stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $160.06, for a total transaction of $601,665.54. Following the completion of the sale, the chief financial officer directly owned 16,884 shares of the company's stock, valued at approximately $2,702,453.04. This trade represents a 18.21% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Moshe Eisenberg also recently made the following trade(s):

• On Wednesday, August 12th, Moshe Eisenberg sold 645 shares of Camtek stock. The stock was sold at an average price of $172.67, for a total transaction of $111,372.15.

Camtek Stock Up 0.5%

Shares of CAMT traded up $0.81 during mid-day trading on Thursday, hitting $175.01. The company's stock had a trading volume of 64,596 shares, compared to its average volume of 517,052. The company has a current ratio of 8.35, a quick ratio of 7.46 and a debt-to-equity ratio of 0.71. The company's 50-day moving average is $158.26 and its 200-day moving average is $163.51. Camtek Ltd. has a 52-week low of $75.75 and a 52-week high of $215.99. The firm has a market capitalization of $8.17 billion, a price-to-earnings ratio of 272.89, a PEG ratio of 3.66 and a beta of 1.58.

Camtek (NASDAQ:CAMT - Get Free Report) last released its quarterly earnings results on Monday, August 10th. The semiconductor company reported $0.78 EPS for the quarter, topping the consensus estimate of $0.76 by $0.02. The firm had revenue of $133.24 million during the quarter, compared to analyst estimates of $130.44 million. Camtek had a return on equity of 22.31% and a net margin of 7.40%.The business's revenue for the quarter was up 8.0% compared to the same quarter last year. During the same period in the previous year, the company posted $0.79 EPS. On average, equities research analysts forecast that Camtek Ltd. will post 3.16 EPS for the current fiscal year.

Hedge Funds Weigh In On Camtek

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Harel Insurance Investments & Financial Services Ltd. boosted its holdings in Camtek by 38.2% in the 1st quarter. Harel Insurance Investments & Financial Services Ltd. now owns 2,302,009 shares of the semiconductor company's stock valued at $349,008,000 after purchasing an additional 636,773 shares during the last quarter. Wasatch Advisors LP raised its holdings in shares of Camtek by 18.6% in the 2nd quarter. Wasatch Advisors LP now owns 3,506,727 shares of the semiconductor company's stock valued at $296,529,000 after buying an additional 550,072 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in Camtek during the fourth quarter worth about $57,772,000. Millennium Management LLC lifted its holdings in Camtek by 169.8% during the 3rd quarter. Millennium Management LLC now owns 479,053 shares of the semiconductor company's stock worth $50,325,000 after buying an additional 301,484 shares in the last quarter. Finally, Nuveen LLC boosted its holdings in Camtek by 723.2% in the fourth quarter. Nuveen LLC now owns 183,859 shares of the semiconductor company's stock valued at $19,758,000 after purchasing an additional 161,524 shares during the period. Hedge funds and other institutional investors own 41.93% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts recently commented on the stock. Evercore reiterated an "outperform" rating and set a $200.00 price objective on shares of Camtek in a research note on Wednesday, May 13th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Camtek in a report on Tuesday. Morgan Stanley reduced their price target on Camtek from $167.00 to $165.00 and set an "equal weight" rating on the stock in a research report on Tuesday. Jefferies Financial Group increased their price objective on Camtek from $185.00 to $200.00 and gave the company a "buy" rating in a report on Wednesday, May 13th. Finally, B. Riley Financial restated a "buy" rating on shares of Camtek in a research note on Monday, April 20th. Seven investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $173.25.

Camtek Company Profile

Camtek Ltd. NASDAQ: CAMT is a provider of automated inspection and metrology solutions for the semiconductor and printed circuit board (PCB) industries. The company develops, manufactures and markets a suite of inline and stand-alone systems that perform high‐resolution 2D and 3D measurements, defect review and process control. Its products are used by integrated device manufacturers, foundries, OSAT (outsourced semiconductor assembly and test) providers, and PCB fabricators to optimize yield, improve product quality and reduce production costs.

Camtek's core offerings include wafer inspection systems that detect and classify defects on patterned wafers, patterned wafer metrology tools for overlay and critical dimension measurements, and advanced packaging inspection platforms for 3D ICs and fan-out wafer-level packaging.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source